Cardio Diagnostics Holdings Inc. Common stock Share Price
NASDAQ: CDIO | Micro CapCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $1.67 | Prev. Close $1.69 | Circuit Range N/A |
Day Range $1.67 - $1.67 | Year Range $0.97 - $7.89 | Volume 100 |
Average Traded $1.67 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Today
As of 9 August 2026, Cardio Diagnostics Holdings Inc. Common stock's share price is $1.67. The stock opened at $1.67, compared to its previous close of $1.69. During today's trading session, Cardio Diagnostics Holdings Inc. Common stock's share price traded between $1.67 and $1.67, with an average price of $1.67. Over the past 52 weeks, the stock has recorded a high of $7.89 and a low of $0.97. In terms of performance, Cardio Diagnostics Holdings Inc. Common stock's share price has declined by 74.23% over the last six months and is down 55.60% on a year-on-year basis.
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
Cardio Diagnostics Holdings Inc. Common stock Stock Fundamentals & Key Indicators
Market Cap $2.92M | PE Ratio (TTM) -0.45 | Dividend Yield N/A |
EPS (TTM) $-3.71 | Revenue (TTM) $14825.00 | Return On Equity (TTM) -93.19% |
Profit Margin -43832.49% | Debt to Equity 0.09 | Quarterly Earnings Growth YoY -21.38% |
Cardio Diagnostics Holdings Inc. Common stock Quarterly Profit & Loss
All figures in USD
Cardio Diagnostics Holdings Inc. Common stock Annual Profit & Loss
All figures in USD
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.60 | $1.67 | +6.03% |
Jul 2026 | $2.20 | $1.57 | -28.08% |
Jun 2026 | $1.93 | $2.19 | +17.74% |
May 2026 | $1.78 | $1.86 | +3.91% |
Apr 2026 | $2.02 | $1.79 | -8.67% |
Mar 2026 | $5.39 | $1.96 | -69.75% |
Feb 2026 | $1.47 | $6.48 | +332.00% |
Jan 2026 | $2.84 | $1.50 | -48.19% |
Dec 2025 | $2.90 | $2.90 | -3.82% |
Nov 2025 | $3.81 | $3.01 | -31.59% |
Oct 2025 | $3.94 | $4.40 | +9.18% |
Sep 2025 | $3.79 | $4.03 | +7.15% |
CDIO Share Price FAQs
What is Cardio Diagnostics Holdings Inc. Common stock share price today?
What is the 52 week high and 52 week low of Cardio Diagnostics Holdings Inc. Common stock stock?
What is CDIO's market capitalisation today?
What is CDIO's net income for the last quarter?
What is the 5 year returns of CDIO?
What is the high & low stock price of CDIO today?
Can I buy CDIO shares in India?